CDTX   $221.38  0.03% Market Closed

Cidara Therapeutics, Inc.
Total Cash 164.37M
totalCashPerShare 23.354
EBITDA -30.11M
Total Debt 4.30M
quickRatio 4.205
currentRatio 4.253
Total Revenue 53.87M
debtToEquity 3.284
Revenue/Share 11.875
ROA -0.1566
ROE -1.53388
grossProfits
freeCashflow -323.88K
operatingCashflow -124.78M
earningsGrowth
revenueGrowth -0.941
grossMargins -0.19295
ebitdaMargins -0.55888003
operatingMargins -36.758278
profitMargins -2.11351
enterpriseValue -66.74M
forwardPE -1.3313253
floatShares 4.21M
sharesOutstanding 7.04M
sharesShort 66.98K
sharesShortPriorMonth 65.14K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.52%
Short Ratio help_outline 3.88%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 28.658
Price To Book help_outline 0.46
earningsQuarterlyGrowth
netIncomeToCommon -112.24M
trailingEps -24.60%
forwardEps -9.96%
enterpriseToEbitda 2.22
lastDividendValue
lastDividendDate
currentQuarterEstimate -4.25 3Q 2024
institutionsCount 33
lastUpdated Nov. 7, 2024, 3:03 p.m.